Tuberculosis and Other Opportunistic Infections

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children

  • Source: Centers for Disease Control and Prevention, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society

  • Publication Date: 6/27/18

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

  • Source: Centers for Disease Control and Prevention, National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America

  • Publication Date: 10/18/17

Treatment of Tuberculosis

  • Source: American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America

  • Publication Date: 10/1/16

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

  • Source: Centers for Disease Control and Prevention

  • Publication Date: 6/1/13

British HIV Association Guidelines for the Treatment of TB/HIV Coinfection

  • Source: British HIV Association

  • Publication Date: 10/1/11

Joint WHO/ILO policy guidelines on improving health worker access to prevention, treatment and care services for HIV and TB

  • Source: World Health Organization, International Labor Organization

  • Publication Date: 4/28/10

Clinical Practice Guidelines for <i>Clostridium difficile</i> Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

  • Source: Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

  • Publication Date: 1/1/10

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

  • Source: Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

  • Publication Date: 8/1/09

Treatment of Clostridium difficile-Associated Disease

  • Source: Leffler DA, Lamont JT

  • Publication Date: 5/1/09

Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals

  • Source: Society for Healthcare Epidemiology of America/Infectious Diseases Society of America

  • Publication Date: 10/1/08

Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach.

  • Source: World Health Organization, United Nations Office on Drugs and Crime, and UNAIDS

  • Publication Date: 1/1/08

Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults

  • Source: Infectious Diseases Society of America/American Thoracic Society

  • Publication Date: 3/1/07

Guidelines for HIV Surveillance Among Tuberculosis Patients

  • Source: World Health Organization/UNAIDS Group on HIV/AIDS/STI Surveillance and the TB/HIV Working Group on the Global Partnership to Stop TB

  • Publication Date: 6/20/04

Update: Adverse Event Data and Revised Recommendations Against Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection

  • Source: American Thoracic Society and the Centers for Disease Control and Prevention

  • Publication Date: 8/8/03

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

  • Source: US Department of Health and Human Services and the Centers for Disease Control and Prevention

  • Publication Date: 6/9/00